Papers
2
Total Citations
1,114
H-Index
2
About
David Stevens is a pioneering figure in chemical biology and molecular diagnostics, whose work bridges fundamental glycobiology and clinical hematology. His landmark 2004 study, "Printed covalent glycan array for ligand profiling of diverse glycan binding proteins," with over 1,100 citations, revolutionized the study of carbohydrate-protein interactions. By adapting standard robotic microarray printing to immobilize amine-functionalized glycans, Stevens created a high-throughput platform containing 200 synthetic and natural glycan sequences. This tool enabled rapid, systematic profiling of lectins, antibodies, and viral receptors, establishing a gold standard for glycomics research and profoundly impacting fields from immunology to infectious disease. More recently, Stevens has driven innovation in precision oncology. His 2012 work on "Fast‐mode duplex qPCR for BCR-ABL1 molecular monitoring" introduced automation and harmonization to RT-qPCR protocols for tracking minimal residual disease in leukemia patients. Though less cited, this contribution is critical for standardizing clinical workflows, improving sensitivity, and enabling reproducible, high-throughput monitoring of treatment response. Stevens’ career exemplifies how foundational tool-building in basic science can translate directly into improved patient care.
Research Focus
Key Achievements
Top Papers
- 1Printed covalent glycan array for ligand profiling of diverse glycan binding proteins1,099 citations · 2004
- 2